Would have been nice of him to have put a name to the collaborator. The good news here is Shire is pressing on with no safety issues and apparently Maza has been doing some real CEO work in putting together a collaboration in the absence of a science officer. So far so good looking forward to some great trial news before year end.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.